Genomic Biomarker Market, By Type (Predictive Biomarkers and Prognostic Biomarkers), By Disease Indication, By Validation, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Genomic Biomarker Market size was valued at USD 7,684.2 Million in 2023, expanding at a CAGR of 18.20% from 2024 to 2032.
Genomic biomarkers are characteristics of DNA and RNA that are used to characterize diseases, choose treatments, and provide diagnostic information. Genomic biomarkers reflect pathological and physiological processes, as well as the reaction of the organism to treatment. One gene, a collection of genes, or the entire genome can have molecular alterations discovered by genomic biomarker testing. There may or may not be substantial supporting evidence for a connection between a genetic biomarker and the risk of contracting a disease. The clinical validity and usefulness of genomic biomarkers are influenced by two factors: genetic epidemiology data and functional laboratory assessments.
Genomic Biomarker Market- Market Dynamics
Growing Cancer Prevalence to Propel Market Growth
The market demand for genomics biomarkers is expected to increase due to the rising prevalence of various cancers, including lung, prostate, ovarian, and breast cancer. Targeting organ systems and diseases is the goal of biomarkers in human health. In particular, biomarkers are becoming more and more common in medical procedures that lead to therapy, critical care, and disease-based diagnosis. There is a growing need for genetic biomarkers worldwide in order to improve the detection and management of chronic illnesses, including cancer and cardiovascular disease. This leads to an increase in the market\'s demand for genomics biomarkers during the projected term.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENOMIC BIOMARKER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
Eurofins Scientific (Luxembourg)
FOUNDATION MEDICINE, INC. (U.S.)
QIAGEN (Germany)
Myriad Genetics, Inc (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
MedGenome (India)
Sema4 (U.S.)
GENOME LIFE SCIENCES (India)
Almac Group (U.K.)
Creative Diagnostics (U.S.)
Quanterix (U.S.)
Others
GLOBAL GENOMIC BIOMARKER MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Predictive Biomarkers
Prognostic Biomarkers
GLOBAL GENOMIC BIOMARKER MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032
Oncology
Cardiovascular Diseases
Neurological Diseases
Renal Disorders
Others
GLOBAL GENOMIC BIOMARKER MARKET, BY VALIDATION- MARKET ANALYSIS, 2019 - 2032
Analytical Validation
Clinical Validation
Clinical Utility
GLOBAL GENOMIC BIOMARKER MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Diagnostic
Research Laboratories
Hospitals
Others
GLOBAL GENOMIC BIOMARKER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Genomic Biomarker Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Genomic Biomarker Market Snippet by Type
2.1.2. Genomic Biomarker Market Snippet by Disease Indication
2.1.3. Genomic Biomarker Market Snippet by Validation
2.1.4. Genomic Biomarker Market Snippet by End User
2.1.5. Genomic Biomarker Market Snippet by Country
2.1.6. Genomic Biomarker Market Snippet by Region
2.2. Competitive Insights
3. Genomic Biomarker Key Market Trends
3.1. Genomic Biomarker Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Genomic Biomarker Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Genomic Biomarker Market Opportunities
3.4. Genomic Biomarker Market Future Trends
4. Genomic Biomarker Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Genomic Biomarker Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Genomic Biomarker Market Landscape
6.1. Genomic Biomarker Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Genomic Biomarker Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
7.1.2. Predictive Biomarkers
7.1.3. Prognostic Biomarkers
8. Genomic Biomarker Market – By Disease Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
8.1.2. Oncology
8.1.3. Cardiovascular Diseases
8.1.4. Neurological Diseases
8.1.5. Renal Disorders
8.1.6. Others
9. Genomic Biomarker Market – By Validation
9.1. Overview
9.1.1. Segment Share Analysis, By Validation, 2023 & 2032 (%)
9.1.2. Analytical Validation
9.1.3. Clinical Validation
9.1.4. Clinical Utility
10. Genomic Biomarker Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
10.1.2. Diagnostic
10.1.3. Research Laboratories
10.1.4. Hospitals
10.1.5. Others
11. Genomic Biomarker Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Genomic Biomarker Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Genomic Biomarker Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Genomic Biomarker Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Genomic Biomarker Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Genomic Biomarker Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Genomic Biomarker Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Thermo Fisher Scientific (U.S.)
12.2.2. F. Hoffmann-La Roche Ltd (Switzerland)
12.2.3. Eurofins Scientific (Luxembourg)
12.2.4. FOUNDATION MEDICINE, INC. (U.S.)
12.2.5. QIAGEN (Germany)
12.2.6. Myriad Genetics, Inc (U.S.)
12.2.7. Bio-Rad Laboratories, Inc. (U.S.)
12.2.8. MedGenome (India)
12.2.9. Sema4 (U.S.)
12.2.10. GENOME LIFE SCIENCES (India)
12.2.11. Almac Group (U.K.)
12.2.12. Creative Diagnostics (U.S.)
12.2.13. Quanterix (U.S.)
12.2.14. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
